florio HAEMO the app and dashboard – developed to support people with haemophilia and their treating physicians

Florio GmbHGermany


Production / Professional


Dr. Ruediger Jankowsky, Bill Cole, James Prince, Julia Geiss, Sebastian Fichtner, Anjali Multani, Karen Carlin, Jeremy Langworthy, Cristhian Leon, Pedro Pereira, Michael Schwarzfischer, Alin Mantale, Karim Muzahidul, Yevhen Harastovych, Caroline Epping


Haemophilia is a rare, genetic disorder in which the ability of a person’s blood to clot is impaired. People with haemophilia (PwH) experience bleeding episodes that can cause pain, irreversible joint damage and life-threatening haemorrhages, and in most cases must self-administer their medication multiple times per week through intravenous injections. florio HAEMO is developed to support people with haemophilia and physicians in managing this disease. It was developed to empower PwH to make informed decisions based on real-world data to support and provide physicians with contextualized patient reported data.


Florio was designed for and has been developed together with the input from people with haemophilia and their care teams. florio HAEMO is intended to monitor haemophilia therapy. It is a CE marked digital medical device, which consists of an app for people with haemophilia, and a dashboard for their treating physicians.

People with haemophilia are encouraged to document their therapy and in many cases need to share the documentation with their physicians. In the past manual documentation was used. With the advent of digital technologies, apps are increasingly applied for documentation as they support real time data transfer and capture data in a digital format.

Based on latest user-centric design, florio HAEMO was developed to empower people with haemophilia on prophylactic treatment with personal insights, including their individual estimated plasma factor level. With its user-friendly and accessible design, people with haemophilia can precisely and comprehensively document injections, bleeds and pains, activities and wellbeing at any moment. The data may then support the patient to develop a better understanding of their own condition and make informed choices for planning their daily life. It is also possible to monitor their medication stock and receive warnings before their supply is exhausted.

With the patient’s permission, the florio HAEMO dashboard provides their healthcare team individual insights with immediate access to their logged data in real-time. This can support meaningful discussions between PwH and their physicians and potentially inform treatment and care planning. Physicians can see the relationship between patient reported data and estimated plasma factor level, placing context around events like bleeds, pain and physical activity.

florio HAEMO was designed to allow PwH to easily document their treatment and to strengthen the relationship between PwH and their treating physicians.


Florio utilizes a human-centric design process, incorporating feedback from real-world users and the iterating designs based on the results of extensive usability testing. Using this feedback from people with haemophilia and health care professionals, our team of designers, engineers and medical experts created florio HAEMO for a great user experience. Recent design iterations have also focused on increasing the usability for users with visual impairment and other accessibility considerations. Since launch florio HAEMO expanded to over 20 countries and 20 languages.


The Interaction Awards are an initiative of the Interaction Design Association (IxDA), a global community of more than 120,000 individuals worldwide dedicated to the professional practice of Interaction Design. Find out how to join your local group and get involved at ixda.org.

© 2012 - 2023 Interaction Design Association